Dr. Sfakianos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5 E 98th street 6th floor
New York, NY 10029Phone+1 212-241-4812- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
- SUNY Downstate Health Sciences UniversityResidency, Urology, 2008 - 2012
- SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 2007 - 2008
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007
Certifications & Licensure
- NY State Medical License 2012 - 2025
- American Board of Urology Urology
Publications & Presentations
PubMed
- BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.Lidagoster, S., Ben-David, R., De Leon, B., Sfakianos, J.> ;Current Oncology. 2024 Feb 16
- Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.Galsky, M., Daneshmand, S., Izadmehr, S., Gonzalez-Kozlova, E., Chan, K., Lewis, S., Achkar, B., Dorff, T., Cetnar, J., Neil, B., D'Souza, A., Mamtani, R., Kyriakopoul...> ;Nature Medicine. 2024 Jan 19
- A multidisciplinary discussion of BladderPath.Marie-Pier St-Laurent, John P Sfakianos, Tracy L Rose, Peter Chung, Wassim Kassouf, Alexandre R Zlotta, Brant Inman, Peter C Black> ;Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada. 2024 Mar 1
- Join now to see all
Journal Articles
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesIsuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology
Authored Content
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018
Press Mentions
- New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
- Ask the Expert: John Sfakianos, M.D.June 17th, 2021
- Novel Immune Checkpoint Axis to Understand BCG Resistance and Improve Treatment in Non-Muscle Invasive Bladder Cancer - Amir Horowitz & John SfakianosMay 10th, 2021
- Join now to see all
Hospital Affiliations
- Mount Sinai Beth IsraelNew York, New York
- The Mount Sinai HospitalNew York, New York
- Mount Sinai MorningsideNew York, New York
- Mount Sinai Hospital of QueensAstoria, New York
- Mount Sinai WestNew York, New York
- NYC Health + Hospitals / South Brooklyn HealthBrooklyn, New York
- Mount Sinai BrooklynBrooklyn, New York
- New York Eye and Ear Infirmary of Mount SinaiNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: